Abstract:Recent work suggests that extracellular (cell-free) nucleic acids, both DNA and RNA species, as well as extracellular nucleosomes can activate blood coagulation and promote thrombosis in vitro and in vivo (1, 2). Indeed, they substantially contribute to the development of microvascular thrombosis which can act as an intravascular immune response to circulating bacteria and has been termed immunothrombosis (3). However, they also foster pathological vessel occlusions as shown in animal models of large vessel thrombosis including deep-vein thrombosis and arterial thrombosis. Large filaments of extracellular nucleosomes that are released from activated neutrophils (neutrophil extracellular traps, NETs) and isolated extracellular nucleosomes support fibrin formation and platelet adhesion/activation via different mechanisms. These include for example stimulation of fibrin formation by degradation of the endogenous anticoagulant tissue factor pathway inhibitor and via activation of proteins involved in the contact pathway of blood coagulation such as factor XII (2, 3). The study by Varju et al. (4) adds a new aspect to the procoagulant role of nucleosome components and NETs. These authors show that isolated eukaryotic DNA and histone proteins such as HIIIS enhance the diameter of thrombus-forming fibrin fibers under in vitro conditions. Moreover, they are found to decrease the permeability of fibrin clots and to enhance the overall stability of such clots. Mechanistically, these effects are mediated by regulation of endogenous anticoagulant and fibrinolytic pathways. Indeed, histone proteins prevented the inactivation of thrombin by antithrombin and DNA reduced plasminogen activation. Furthermore, NETs released from isolated neutrophils suppressed t-PA-promoted fibrinolysis. Together with earlier work, these results further corroborate the conclusion that extracellular nucleosomes and their major components target the coagulation system at different levels and that their overall effect is to enhance fibrin formation. It will be of interest to clarify in the future whether the stabilization of fibrin clots by histones, DNA and nucleosomes as shown in (4) contributes to the prothrombotic role of NETs and extracellular nucleosomes in vivo.

Effect of neutrophil extracellular traps (NET) on thrombosis: A literature review

Neutrophil Extracellular Traps in Arterial and Venous Thrombosis

Impact of Neutrophil Extracellular Traps on Thrombosis Formation: New Findings and Future Perspective

The effect of neutrophil extracellular traps in venous thrombosis

[Research progress on neutrophil extracellular traps in tumor].

Neutrophil extracellular traps: neutrophil’s afterlife

Neutrophil Extracellular Traps Affecting Cardiovascular Health in Infectious and Inflammatory Diseases

Worsening Thrombotic Complication of Atherosclerotic Plaques Due to Neutrophils Extracellular Traps: A Systematic Review

Role of Neutrophils and NETs in Animal Models of Thrombosis

Neutrophil Extracellular Traps: Signaling Properties and Disease Relevance

Abstract 569: Neutrophil Extracellular Traps Promote Thrombin Generation Through Platelet-Dependent and -Independent Mechanisms

NET-(works) in arterial and venous thrombo-occlusive diseases

Neutrophil Extracellular Traps and Their Implications in Cardiovascular and Inflammatory Disease

The Role of Neutrophil Extracellular Traps in Central Nervous System Diseases and Prospects for Clinical Application

Neutrophil Extracellular Traps and Thrombolysis Resistance: New Insights for Targeting Therapies

Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development

Neutrophil Extracellular Traps and Endothelial Dysfunction in Atherosclerosis and Thrombosis

Impact of neutrophil extracellular traps on fluid properties, blood flow and complement activation

Neutrophil extracellular traps mediate neuro-immunothrombosis

Extracellular DNA and histones as thrombus stabiliser

The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis